Rise Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-965
Closed -$18K – 1184
2025
Q3
$18K Buy
965
+15
+2% +$280 0.01% 645
2025
Q2
$17.5K Buy
950
+16
+2% +$284 0.01% 616
2025
Q1
$16.3K Sell
934
-335
-26% -$5.65K 0.01% 632
2024
Q4
$22K Buy
1,269
+20
+2% +$365 0.01% 597
2024
Q3
$23.2K Buy
1,249
+22
+2% +$371 0.01% 587
2024
Q2
$18.9K Buy
1,227
+25
+2% +$357 0.01% 667
2024
Q1
$17.8K Buy
+1,202
New +$16.6K 0.01% 727

Other funds holding SBRA

Rise Advisors's SBRA Position: Q4 2025 in Review

Rise Advisors sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 965 shares — an estimated $18K sold.

Rise Advisors first reported a position in SBRA in Q1 2024 and held it in 7 quarters. The position peaked at $23.2K in Q3 2024. 441 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

  • Rise Advisors reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 965 Sabra Healthcare REIT shares in Q4 2025, an estimated $18K.
  • Rise Advisors first reported a position in Sabra Healthcare REIT in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Sabra Healthcare REIT position peaked at $23.2K in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.